Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis

References

• LauWYPrimary liver tumorsSemin Surg Oncol2000192 135 14411126378
   PubMedGoogle Scholar
• IARCGLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012IARC2012
   Google Scholar
• PoonRTFanSTNgIOWongJSignificance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisalAnn Surg20002314 544 55110749616
   PubMed Web of Science ®Google Scholar
• BruixJShermanMAmerican Association for the Study of Liver DiseasesManagement of hepatocellular carcinoma: an updateHepatology2011533 1020 102221374666
   PubMed Web of Science ®Google Scholar
• AvilaMABerasainCSangroBPrietoJNew therapies for hepatocellular carcinomaOncogene20062527 3866 388416799628
   PubMed Web of Science ®Google Scholar
• GretenTFMannsMPKorangyFImmunotherapy of HCCRev Recent Clin Trials200831 31 3918474013
   PubMedGoogle Scholar
• HongYPLiZDPrasoonPZhangQImmunotherapy for hepatocellular carcinoma: from basic research to clinical useWorld J Hepatol201577 980 99225954480
   PubMedGoogle Scholar
• IntronaMGolayJRambaldiACytokine Induced Killer (CIK) cells for the treatment of haematological neoplasmsImmunol Lett20131551–2 27 3024084446
   PubMed Web of Science ®Google Scholar
• LinnYCHuiKMCytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemiaLeuk Lymphoma2003449 1457 146214565644
   PubMed Web of Science ®Google Scholar
• AlvarnasJCLinnYCHopeEGNegrinRSExpansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantationBiol Blood Marrow Transplant200174 216 22211349808
   PubMed Web of Science ®Google Scholar
• JiangJWuCLuBCytokine-induced killer cells promote antitumor immunityJ Transl Med201311 8323536996
   PubMed Web of Science ®Google Scholar
• MesianoGTodorovicMGammaitoniLCytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumorsExpert Opin Biol Ther2012126 673 68422500889
   PubMed Web of Science ®Google Scholar
• WengDSZhouJZhouQMMinimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomasJ Immunother2008311 63 7118157013
   PubMed Web of Science ®Google Scholar
• DongHLiQWangJZhangTKongDLA randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinomaDig Liver Dis2009411 36 4118818130
   PubMedGoogle Scholar
• HaoMZLinHLChenQYeYBChenQZChenMSEfficacy of transcatheter arterial chemoembolization combined with cytokine-induced killer cell therapy on hepatocellular carcinoma: a comparative studyChin J Cancer2010292 172 17720109346
   PubMedGoogle Scholar
• HuangZMLiWLiSCytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patientsJ Immunother2013365 287 29323719239
   PubMed Web of Science ®Google Scholar
• PanKLiYQWangWThe efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patientsAnn Surg Oncol20132013 4305 431123892527
   PubMed Web of Science ®Google Scholar
• LeeJHLeeJHLimYSAdjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinomaGastroenterology20151487 1383 1391.e625747273
   PubMed Web of Science ®Google Scholar
• TakayamaTSekineTMakuuchiMAdoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trialLancet20003569232 802 80711022927
   PubMed Web of Science ®Google Scholar
• LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJ Clin Epidemiol20096210 e1 e3419631507
   PubMed Web of Science ®Google Scholar
• HigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 updated March 2011The Cochrane Collaboration2011
   Google Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials20078 1617555582
   PubMed Web of Science ®Google Scholar
• YuXZhaoHLiuLA randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinomaJ Clin Immunol2014342 194 20324337625
   PubMed Web of Science ®Google Scholar
• DengWJ CJLuoYJXiangGYEfficacy and safety of min-imally invasive treatment combined with autologous CIK cellsinfusionLing Nan Xian Dai Ling Chuang Wai Ke201313 29 31
   Google Scholar
• HeXBWangJHuJHCIK cells combined with TACE treatmentof primary liver cancer randomized controlled studySi ChuanXi Xue201233 1696 1697
   Google Scholar
• HuangLXZhouQMXiaJCMinimally invasive treatmentcombined with autologous CIK cell therapy for primary hep-atocellular carcinoma: safety and efficacyGuang Dong Yi Xue200728 1466 1468
   Google Scholar
• ZhangZNXuYMChenFXClinical study on the treatment of advanced hepatocellular car-cinoma by CIK cellDong Nan Guo Fang Yi Yao20068 84 87
   Google Scholar
• TongLQZhaoHFYouLGTransarterial chemoembolization combined with autologouscytokine-induced killer cells therapy for primary liver cancerZhong Guo Pu Tong Wai Ke Za Zhi201322 9
   Google Scholar
• HaoMZChenQYeYBTranscatheter arterial chemoembolization combined with cytokine-induced killers in treatment of hepatocellular car-cinomaZhong Guo Zhong Liu Sheng Wu Zhi Liao Za Zhi200613 303 305
   Google Scholar
• WangJPLiWHuangZLValue of CIK in the treatment of TACE combined with RFA for HCC in long-term survival and prognostic analysisZhonghua Yi Xue Za Zhi20129243 3062 306623328379
   PubMedGoogle Scholar
• ShiYGaoCJChenFXXuYMDongSLCytokine-induced killer cell for interventional chemotherapy of hepatocellular carcinomaJ Interv Radiol2007164 235 239
   Google Scholar
• YUWYEYZhouDEffect of postoperative transcatheter arterial chemoembolization combined with cytokine-induced killer immunotherapy on recurrence and survival rate of hepatocellular carcinoma patientsJ Min Invasive Med200945 459 461
   Google Scholar
• GuoWLiuLWuDDendritic cell-cytokine induced killer cell immunotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: safety and efficacyNan Fang Yi Ke Da Xue Xue Bao2014345 674 67824849434
   PubMedGoogle Scholar
• SterneJASuttonAJIoannidisJPRecommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trialsBMJ2011343 d400221784880
   PubMed Web of Science ®Google Scholar
• MaYXuYCTangLZhangZWangJWangHXCytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safetyExp Hematol Oncol201211 1123210562
   PubMedGoogle Scholar
• LiXDaiDSongXLiuJZhuLXuWA meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinomaClin Res Hepatol Gastroenterol2014385 583 59124924902
   PubMed Web of Science ®Google Scholar